Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07671885 |
| Consolidated Lead Sponsor | Tokyo Women's Medical University |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 950 participants (ESTIMATED) |
| Registered Start Date | 2026-01-28 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Chiba Cancer Center | Chiba, Japan | Open Hospital Dossier -> |
| National Hospital Organization Kyushu Cancer Center | Fukuoka, Japan | Open Hospital Dossier -> |
| Fukushima Medical University Hospital | Fukushima, Japan | Open Hospital Dossier -> |
| Hiroshima University Hospital | Hiroshima, Japan | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.